FLXN

ZILRETTA®

Osteoarthritis Knee Pain

Quarterly Sales (Approved)

Exp Date

August 31,2020 (Est)

Amp Volatility Score

Catalyst Info & Data Links

TITLE: ZILRETTA® in Osteoarthritis Knee Pain - Quarterly Sales


WHAT IS THE CATALYST EVENT?

  • Quarterly Sales


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • August 31, 2020 (Est)


PRIOR DATA/EVENTS

PRESS RELEASES

COMPETITORS

MARKET

  • ~15 million have osteoarthritis (OA) of the knee in U.S (learn more)

MECHANISM OF ACTION / RATIONALE

  • Triamcinolone acetonide is a corticosteroid with anti-inflammatory and immunomodulating properties. It binds to and activates the glucocorticoid receptor, leading to activation of anti-inflammatory transcription factors such as lipocortins and inhibition of inflammatory transduction pathways by blocking the release of arachidonic acid and preventing the synthesis of prostaglandins and leukotrienes.


Updated by HC

#FLXN, #ZILRETTA, #triamcinolone_acetonide, #OA, #knee_pain

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

FLXN's Preliminary Q2 ZILRETTA...

Flexion Therapeutics reported ZILRETTA (triamcinolone acetonide extended-release injectable suspension) preliminary net sales of $15.4 million in the second quarter. Flexion expects to report its com...

Will FLXN stock pop in 2020?...

We were excited in mid-2019 about FLXN when sales of its osteoarthritis knee pain med, ZILRETTA, showed strong quarterly growth. Unfortunately, FLXN's valuation is down 25% in 2020. Find out why by c...

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon